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Surface acoustic wave (SAW) biosensors allow the users to detect label-free binding events in
the liquid phase, giving information on affinity (KD), kinetics (kon and koff), viscoelastic effects
and conformational changes. Therefore, one of the interaction partners (ligand) is immobilized
on a sensor chip. After analyte interaction, changes in the surface-bound material and
configuration result in a modified oscillation of the surface acoustic wave. The phase of the
wave is shifted on mass changes. Viscoelastic and conformational characteristics are indicated
by a change in amplitude. Both effects can be differentiated and are detected independently
for interaction analysis.
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SAW biosensors have broad applications in different scientific fields. However, their pharmaceutical applications in drug R&D as well as in QA/QC are rather
limited. Therefore, we want to exploit different pharmaceutical applications of the SAW biosensor. Preliminary data is presented below.
Application I: Functional quality control of different chemically-modified somatropin batches. Different batches of chemically-modified somatropin will be
evaluated for their binding to the human growth hormone antibody (hGHAB) and later-on the human growth hormone binding protein (hGHBP).
Application II: Functional quality control of small molecules and peptides. SAW responses are proportional to the molecular weight of the bound analyte, which
makes binding of small molecules and peptides onto an immobilized ligand problematic. A way to overcome this problem is to change the orientation, i.e.
immobilize the small molecule or peptide. However, since the amount of functional groups is rather limited, alternative methods has to be followed instead of
the standard amine coupling. Our first results with opioid peptides and delta opioid receptor (DOR) membrane preparations are presented below.
1. Random immobilization of hGHAB via amine coupling
EDC/NHS EthanolaminehGHAB immobilisation
2. Binding experiment between somatropin and immobilized hGHAB
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The binding characteristics 
were  analysed (Scrubber2):
KD 114.76 nM
kon 1491.0 M
-1 s-1
koff 1.711E-4 s
-1
3. Binding experiment DOR membrane preparations and immobilized 
opioid peptides
Leu-enkephalin
Negative control
SBO-121
1. Directed immobilization of peptides
C
O
O
H
C
O
O
H
C
O
O
H
C
O
O
H
Alkanethiol with -COOH end groups
modified Sensor Chip
+ EDC/NHS
+ EDC
+ peptide
+ carbohydrazide
COOH
pH 4.5
O
C
H
+ ethanolamine
+ carbohydrazide
modified peptide
C
O
OC
H
H
C
O
OC
H
H
H
O
H
O
2. Quality control of the carbohydrazide modified Leu-enkephalin (LC/MS)
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Application I: Functional quality control of different NOTA-somatropin batches.
Immobilization of hGHAB and initial binding experiments were successful. Although the affinity of the hGHAB for somatropin was not reported, the measured KD
value is within the expected affinity for antibodies to their antigens. In future experiments, the affinity of different NOTA-somatropin batches for hGHBP will be
evaluated.
Application II: Functional quality control of small molecules and peptides.
A new immobilization method was evaluated. Leu-enkephalin and a new peptide (SBO-121) were both modified with carbohydrazide on the C-terminus. QC-
analysis (LC/MS) of modified Leu-enkephalin showed that only small fractions were carbohydrazide-modified, so further reaction optimization needs to be
performed. However, an initial binding experiment showed promising results.
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